These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32873702)

  • 1. p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma.
    Guo S; Wang Y; Rohr J; Shang L; Ma J
    J Clin Pathol; 2021 Oct; 74(10):641-645. PubMed ID: 32873702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between p63 and p53 expression in normal and neoplastic breast tissue.
    Ribeiro-Silva A; Zambelli Ramalho LN; Britto Garcia S; Zucoloto S
    Arch Pathol Lab Med; 2003 Mar; 127(3):336-40. PubMed ID: 12653579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor histologic tumor response after adjuvant therapy in basal-like HER2-positive breast carcinoma.
    Zhao D; Fu X; Rohr J; Wang Y; Li M; Zhang X; Qin J; Xu M; Li C; Sun G; Wang Z; Guo S
    Pathol Res Pract; 2021 Dec; 228():153677. PubMed ID: 34775151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of snail in metaplastic breast carcinoma.
    Nassar A; Sookhan N; Santisteban M; Bryant SC; Boughey JC; Giorgadze T; Degnim A
    Diagn Pathol; 2010 Nov; 5():76. PubMed ID: 21110878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
    Koker MM; Kleer CG
    Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
    Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
    J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies?
    Ribeiro-Silva A; Ramalho LN; Garcia SB; Zucoloto S
    Braz J Med Biol Res; 2004 Jan; 37(1):89-95. PubMed ID: 14689049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?
    Wang X; Stolla M; Ring BZ; Yang Q; Laughlin TS; Rothberg PG; Skinner K; Hicks DG
    Hum Pathol; 2016 Sep; 55():196-201. PubMed ID: 27246177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features.
    Guo W; Wang W; Zhu Y; Zhu X; Shi Z; Wang Y
    Int J Clin Exp Pathol; 2015; 8(7):8008-17. PubMed ID: 26339367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas.
    Chartier S; Brochard C; Martinat C; Coussy F; Feron JG; Kirova Y; Cottu P; Marchiò C; Vincent-Salomon A
    Histopathology; 2023 Apr; 82(5):664-671. PubMed ID: 36527253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of tumour suppressor protein p53 and its regulator MDM2 in a cohort of breast cancer patients in a Tertiary Hospital in Ghana.
    Opoku F; Bedu-Addo K; Titiloye NA; Atta Manu E; Ameh-Mensah C; Duduyemi BM
    PLoS One; 2021; 16(10):e0258543. PubMed ID: 34695137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer.
    Duman BB; Sahin B; Acikalin A; Ergin M; Zorludemir S
    J BUON; 2013; 18(1):44-50. PubMed ID: 23613387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
    Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
    Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.
    Gudlaugsson E; Skaland I; Undersrud E; Janssen EA; Søiland H; Baak JP
    Mod Pathol; 2011 Apr; 24(4):502-11. PubMed ID: 21317878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.
    Darb-Esfahani S; Denkert C; Stenzinger A; Salat C; Sinn B; Schem C; Endris V; Klare P; Schmitt W; Blohmer JU; Weichert W; Möbs M; Tesch H; Kümmel S; Sinn P; Jackisch C; Dietel M; Reimer T; Loi S; Untch M; von Minckwitz G; Nekljudova V; Loibl S
    Oncotarget; 2016 Oct; 7(42):67686-67698. PubMed ID: 27611952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
    Cakir A; Gönül II; Uluoğlu O
    Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
    Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
    J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung.
    Choy B; Findeis-Hosey JJ; Li F; McMahon LA; Yang Q; Xu H
    Int J Clin Exp Pathol; 2013; 6(11):2542-7. PubMed ID: 24228118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.